Rubius Therapeutics Inc
RUBY·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$16.43
Today
+0.0%
YTD
+0.0%
About
Rubius Therapeutics is a healthcare firm operating within the US. It develops red cell therapeutics (RCTs) to treat patients with severe diseases. Founded in 2013, the firm has headquarters in Cambridge, Massachusetts. It is listed on the NASDAQ GS stock market using the ticker RUBY. Identify the best time to invest in this stock by following RUBY share price movements with your eToro watchlist.
Price chart
Closing price history for RUBY (1D candles).
No daily candle data is currently available for this instrument.
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.03
P/S (TTM)0.00
P/B (TTM)0.34
Market cap$5.15M
Cap tierMicro-cap
Industry avg P/E-2.16
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-185.31%
ROA-105.35%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$1.99
Free cash flow$-155.45M
Total debt$1.10M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.65
Employees6
Next earnings9 May '23
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.